Jesper Falkesgaard Højen

Aarhus University

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (14)

Eva Sædder

Aarhus University

DENMARK

View details

Klara Lenart

Rockefeller University

UNITED STATES

View details

Rodrigo Arcoverde Cerveira

Karolinska University Hospital

SWEDEN

View details

Mads Kjolby

Aarhus University Hospital

DENMARK

View details

Rasmus Offersen

Ragon Institute of MGH, MIT and Harvard

UNITED STATES

View details

Dorthe G. Bove

DENMARK

View details

Ida Monrad Johannsen

Aarhus University

DENMARK

View details

Jesper Gunst

Aarhus University

DENMARK

View details

Jillian Lau

Peter Doherty Institute

AUSTRALIA

View details

Rikke Olesen

Aarhus University

DENMARK

View details

Isik Somuncu Johansen

University of Southern Denmark

DENMARK

View details

Paul Denton

Assistant Professor (Tenure Track)

University of Nebraska Omaha

UNITED STATES

View details

Lars Peter Nielsen

Ass. professor

Aarhus Universitet Health

DENMARK

View details

Stine Sofie Frank Nielsen

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jesper Falkesgaard Højen

Research Interests

Explore related searches

Contact this professor

Articles (12)

International nomenclature guidelines for the IL-1 family of cytokines and receptors

Pharmacologic inhibition of NLRP3 reduces the levels of α-synuclein and protects dopaminergic neurons in a model of Parkinson’s disease

Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial

A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling

SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.

Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety

SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses

Broadly neutralizing antibodies combined with latency-reversing agents or immune modulators as strategy for HIV-1 remission.

Broadly neutralizing antibodies combined with latency-reversing agents or immune modulators as strategy for HIV-1 remission

The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies.

Collaborators (14)

Eva Sædder

Klara Lenart

Rodrigo Arcoverde Cerveira

Mads Kjolby

Rasmus Offersen

Dorthe G. Bove

Ida Monrad Johannsen

Jesper Gunst

Jillian Lau

Rikke Olesen

Isik Somuncu Johansen

Paul Denton

Lars Peter Nielsen

Stine Sofie Frank Nielsen

Make your next move.